THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,960 | -16.8% | 24,937 | -0.2% | 0.00% | – |
| Q2 2023 | $258,503 | -4.8% | 24,988 | -0.2% | 0.00% | – |
| Q1 2023 | $271,593 | +120.5% | 25,043 | +127.9% | 0.00% | – |
| Q4 2022 | $123,179 | +9.9% | 10,988 | -50.0% | 0.00% | – |
| Q3 2022 | $112,112 | +12.1% | 21,978 | +98.5% | 0.00% | – |
| Q2 2022 | $100,000 | -4.8% | 11,074 | +0.7% | 0.00% | – |
| Q1 2022 | $105,000 | -13.9% | 10,996 | -0.0% | 0.00% | – |
| Q4 2021 | $122,000 | – | 10,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |